ANGIODYNAMICS INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Angiodynamics, Inc. on October 10, 2006, covering events occurring on October 9, 2006. The filing discloses the appointment of a new senior executive officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a disclosure of personnel changes rather than a financial results report.
Material Changes
The primary material change is the appointment of Robert D. Mitchell to the newly created position of Executive Vice President and Chief Operating Officer, effective December 1, 2006. Mr. Mitchell brings experience from Millimed Holdings, Inc., Align Technology, Inc., and Cook Incorporated.
Compensation and Equity Grants
- Base Salary: $270,000 annually.
- Signing Bonus: $50,000 cash.
- Annual Bonus: Eligible for the Management Profitability Bonus Program with a target of 35% of base salary for fiscal 2007.
- Stock Options: 40,800 non-qualified stock options vesting in four equal annual installments starting one year after the grant date.
- Restricted Stock Units (RSUs): 4,000 units vesting on May 30, 2009, contingent on continued employment.
- Performance Shares: 4,000 shares subject to achievement of EPS and revenue goals over three fiscal years starting in 2007.
Outlook and Risks
The filing does not contain specific guidance, outlook, or risk factors beyond the standard disclosure that there are no undisclosed arrangements or family relationships influencing the appointment.
Key Facts for Investor Verification
- Verify the effective start date of the new COO (December 1, 2006).
- Confirm the vesting schedule and performance metrics for the 4,000 performance shares.
- Review the attached press release (Exhibit 99.1) for additional strategic context regarding the appointment.